Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Minority Predoctoral Fellowship Program
Polymerizing Actin: Signals to P21 of ARP2/3
Behavioral Interventions to Prevent the Further Spread O
Branched Chain Amino Acid Metabolism
Transformation by Polyomaviruses
Recently added grants:
PED Screen: Pediatric Sepsis EHR Registry, Clinical Outcomes, and Predictive Model
Implementing an Intervention to Address Social Determinants of Health in Pediatric Practices
Boston University Conference on Language Development
Early Environment, Developmental Epigenetics, and Adult Colonic Diseases
Building Diversity in Biomedical Sciences
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-006
Application #
6828776
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant